Treatment with oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L showed enhanced in vitro efficacy compared to AdV5/3-D24 in all tested mesothelioma cell lines. This evidence concerns the gene CD40LG and mesothelioma.